Fundraising FoxVicapsys Life Sciences
OTC: VICPSawanee, US · Florida corporation
Find your way into Vicapsys Life Sciences
Sign up to see every warm intro you have to Vicapsys Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vicapsys Life Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JW
Jeffrey WrightChief Financial Officer
JW
Jeffery WrightChief Financial Officer (Principal Financial and Accounting Officer)
Board
CF
Charlie FarraharBoard director
CD
Colleen DelaneyBoard director
DJ
Dorothy JordanBoard director
RR
Richard RosenblumBoard director
Reported raises · per SEC filings
Form D private placements$380K disclosed across 2 of 3 rounds · 2017–2023
▶$330KraisedJul 2023 · 1 investors · BiotechnologyRule 506(b)
▶$330KraisedJul 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Federico PierExecutive Officer, Director
- Charlie FarraharDirector
- Colleen DelaneyDirector
- Dorothy JordanDirector
- Jeffrey WrightExecutive Officer
- Richard RosenblumDirector
- Offering amount
- $330K
- Amount sold
- $330K
- Sales commissions
- $23.1K
- Placement agents
- Titan Partners Group LLC, a division of American Capital Partners, LLC
- First sale
- Jun 2023
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$50KraisedFeb 2018 · 3 investors · BiotechnologyRule 506(b)
▶$50KraisedFeb 2018 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John T. Potts, Jr.Director
- Charles FarraharExecutive Officer
- Federico PierDirector
- Leonard PotterDirector
- Stephen J. McCormackDirector
- Dorothy JordanDirector
- William H. CarsonDirector
- Steve GorlinExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $50K
- Sales commissions
- $600K
- Placement agents
- Titan Securities
- First sale
- Jan 2018
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶Undisclosed amountofferedJan 2018 · 52 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedJan 2018 · 52 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steve GorlinExecutive Officer, Director
- Leonard PotterDirector
- Stephen J. McCormackDirector
- Dorothy JordanDirector
- Federico PierDirector
- John T. Potts, Jr.Director
- William H. CarsonDirector
- Charles FarraharExecutive Officer
- First sale
- Dec 2017
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$17.3Mvaluation at IPONov 2009 · $0.50/share · S-1/A
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Frequently asked questions
- How much funding has Vicapsys Life Sciences raised?
- Vicapsys Life Sciences has disclosed $380K raised across 2 of its 3 known rounds.
- Where is Vicapsys Life Sciences headquartered?
- Vicapsys Life Sciences is headquartered in Sawanee, US.